Innovative Technology Scopio Labs specializes in AI-driven digital pathology solutions that enhance diagnostic accuracy and speed, making it a compelling partner for healthcare providers seeking cutting-edge cell analysis platforms.
Strategic Partnerships The company's collaboration with Beckman Coulter and recent funding milestones demonstrate its market credibility and potential for expansion into global medical device distributions and diagnostics markets.
Funding Momentum With a total funding of 66 million USD, including significant Series D investments, Scopio Labs is well-positioned to scale its innovative platforms and penetrate larger healthcare institutions.
Regulatory Approvals The CE-Marked Full-Field Bone Marrow Aspirate application highlights Scopio Labs’ focus on regulatory compliance, facilitating market entry and adoption within healthcare systems across different regions.
Market Recognition Recognition as one of Fast Company's Most Innovative Companies in 2023 underscores the company's competitive edge and attractiveness as a technology solution provider for advanced clinical workflows.
$10M$25M
$1M
$1B$10B
$250M$500M
$1M
$1B$10B
$500M$1BScopio Labs uses 8 technology products and services including LinkedIn Ads, GitHub, Salesforce, and more. Explore Scopio Labs's tech stack below.
| Scopio Labs Email Formats | Percentage |
| First@scopiolabs.com | 59% |
| First.Last@scopiolabs.com | 36% |
| FirstL@scopiolabs.com | 3% |
| Last@scopiolabs.com | 2% |
Medical Equipment ManufacturingIsrael51-200 Employees
Scopio Labs is transforming cell morphology analysis, offering fully digital applications, platforms, and diagnostic support that enhance clinical workflows. By assisting lab experts with fast, early, and accurate detection and diagnosis of disease, Scopio expedites patients' access to life-saving treatments.
.
Company Overview
Media & News
Funding & FinancialsScopio Labs has raised a total of $66M of funding over 2 rounds. Their latest funding round was raised on Feb 09, 2022 in the amount of $50Mas a Series C.
Scopio Labs's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsScopio Labs has raised a total of $66M of funding over 2 rounds. Their latest funding round was raised on Feb 09, 2022 in the amount of $50Mas a Series C.
Scopio Labs's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com